J. Wood Capital Advisors LLC and Jason Wood File Schedule 13G for Cyclerion Therapeutics, Inc.

J. Wood Capital Advisors LLC and Jason Wood have filed a Schedule 13G with the SEC, reporting beneficial ownership of 5.4% of the common stock of Cyclerion Therapeutics, Inc. The filing indicates that J. Wood Capital Advisors LLC is the record holder of 181,818 shares, and Jason Wood, as the managing member of J. Wood Capital Advisors LLC, may be deemed to share beneficial ownership of these shares. The filing is made pursuant to Rule 13d-1(c) and includes a joint filing agreement. The shares are not held for the purpose of influencing the control of the issuer.